Officials at India-based Syngene International, a CRDMO, report that the company executed site upgrades to accelerate drug discovery and development. The investments included a dedicated peptide ...
The two companies enter into a multi-year strategic agreement to accelerate drug development timelines, strengthen U.S. manufacturing capabilities and help bring lifesaving medicines to patients ...
The Peptide-ExplorerLT ™ is designed for scientists who need to optimize and explore linear peptide synthesis. The product is a high-spec flow chemistry system that uses continuous flow. The product ...
BENGALURU and HYDERABAD, India, Oct. 17, 2025 /PRNewswire/ -- Syngene International, a global contract research, development, and manufacturing organization (CRDMO), announced site upgrades to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback